Jianfeng Chen
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 27
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 8
- Complement system in diseases 7
- Co-authors
- Padmanee SharmaJianjun GaoJames P. AllisonLewis Z. ShiHao ZhaoJennifer A. WargoLiangwen XiongTenghui Chen
- Journals
- Cell Death and Disease (5 papers)Molecules (3 papers)Journal of Biological Chemistry (3 papers)International Immunopharmacology (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Jianfeng Chen
118 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Immunology 1.4k
- Oncology 1.6k
- Cancer Research 651
- Molecular Biology 1.5k
- Nephrology 92
Countries citing papers authored by Jianfeng Chen
This map shows the geographic impact of Jianfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Chen more than expected).
Fields of papers citing papers by Jianfeng Chen
This network shows the impact of papers produced by Jianfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Chen. The network helps show where Jianfeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianfeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 19 | |
| 5 | 2024 | 17 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 15 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 45 | |
| 14 | 2019 | 35 | |
| 15 | Inhibition of human glioblastoma cell invasion involves PION@E6 mediated autophagy process | 2019 | 1 |
| 16 | Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway | 2019 | 1 |
| 17 | 2015 | 46 | |
| 18 | 2015 | 27 | |
| 19 | 2012 | 44 | |
| 20 | 2007 | 36 |
About Jianfeng Chen
Jianfeng Chen is a scholar working on Immunology, Cancer Research, Complementary and alternative medicine, Molecular Biology and Oncology, having authored 123 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (8 papers), Autophagy in Disease and Therapy (7 papers), Complement system in diseases (7 papers), RNA modifications and cancer (6 papers), Estrogen and related hormone effects (6 papers) and Natural product bioactivities and synthesis (6 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.6k citations), Cancer Research (651 citations), Molecular Biology (1.5k citations) and Nephrology (92 citations). Jianfeng Chen has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Padmanee Sharma, Jianjun Gao, James P. Allison, Lewis Z. Shi, Hao Zhao, Jennifer A. Wargo, Liangwen Xiong, Tenghui Chen, Qiuming He and Patrick Hwu. Their work appears in journals such as Cell Death and Disease, Molecules, Journal of Biological Chemistry, International Immunopharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.